In Silico Modeling Entelos specializes in in silico modeling and simulation software for pharmaceutical, healthcare, and consumer industries, offering predictive technologies to lower development risks and costs significantly.

Systems Biology Mapping With PhysioLab® platforms and deep systems biology data, Entelos provides highly predictive analyses aiding in the development of safer and more effective drugs, foods, and consumer products for targeted markets.

Personalized Medicine Entelos' expertise in understanding patient variability drivers is relevant for personalized medicine, showcasing potential for solutions that align with the emerging trends in healthcare.

Market Expansion Given the strategic focus on prediction and risk assessment, Entelos is primed for market expansion by partnering with scientific discovery and development organizations seeking unique insights and decision support in various product development phases.

Financially Competitive With revenue in the range of $100 million to $1 billion, Entelos stands as a financially competitive player in the biotechnology research industry, attracting sales opportunities from organizations looking for stable and established technology partners.